Professor Weinstock-Rosin is an internationally renowned scientist, known for her groundbreaking research in neuropharmacology. She is best known as the inventor of Exelon, one of the first drugs developed to treat Alzheimer’s disease, for which she received the U.S. Institute of Aging Award in 2000. Her pioneering work has advanced understanding of neurodegeneration, the effect of prenatal stress on behavior and development, and the mechanisms underlying hypertension.
She studied at London University, where she earned her Ph.D. in pharmacology, and began her academic career as a lecturer at St. Mary’s Hospital Medical School.
In 1969, she made Aliyah to Israel and was appointed Head of the Department of Physiology and Pharmacology at Tel Aviv University. After a sabbatical at the U.S. National Institutes of Health, she joined the Hebrew University of Jerusalem in 1977, where she later chaired the Department of Pharmacology.
In recognition of her immense contributions to medical science, she was awarded the Israel Prize in Medical Research in 2014. Today, her research continues to focus on developing new therapies to prevent Alzheimer’s disease and fibrosis in lung and liver conditions.
Professor Marta Weinstock-Rosin was born in Austria in 1935 and escaped with her parents and brother to England in 1939 to avoid Nazi persecution. Her extraordinary journey, from a young refugee to one of Israel’s foremost scientists, embodies courage, determination, and a lifelong devotion to improving human health.
Prof. Marta Weinstock-Rosin lives in Jerusalem and has 4 children, 20 grandchildren and 17 great-grandchildren, all of whom live in Israel.
Prof. Marta Weinstock-Rosin made Aliyah from England in 1969.